Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Severe Hemophilia A

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Beijing tongren hospital,CMU, Beijing, China

    Contact: Study coordinator (Liang Wang)
  • XiangYa Hospital CentralSouth University, Changsha, China

    Contact: Study coordinator (Xielan Zhao)
  • The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

    Contact: Study coordinator (Shifeng Lou)
  • Fujian Medical University Union Hospital, Fuzhou, China

    Contact: Study coordinator (Fenge Yang)
  • Nanfang Hospital of Southern Medical University, Guangzhou, China

    Contact: Study coordinator (Jing Sun)
  • The First Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou, China

    Contact: Study coordinator (Wenyuan Mai)
  • Anhui Provincial Hospital, Hefei, China

    Contact: Study coordinator (Xiaoyu Zhu)
  • Jinan central hospital, Jinan, China

    Contact: Study coordinator (Yun Chen)
  • The First Affiliated Hospital of Shandong First Medical University, Jinan, China

    Contact: Study coordinator (Kehong Bi)
  • The Second Affiliated Hospital of Kunming Medical University, Kunming, China

    Contact: Study coordinator (Zeping Zhou)
  • The First Hospital of Lanzhou University, Lanzhou, China

    Contact: Study coordinator (Yaming Xi)
  • Jiangxi Provincial People's Hospital, Nanchang, China

    Contact: Study coordinator (Chenhao Jin)
  • Nanjing Drum Tower Hospital, Nanjing, China

    Contact: Study coordinator (Rongfu Zhou)
  • Affiliated Hospital of Nantong University, Nantong, China

    Contact: Study coordinator (Hong Liu)
  • The Affiliated Hospital of Qingdao University, Qingdao, China

    Contact: Study coordinator (Zhongguang Cui)
  • Ruijin Hospital, Shanghai Jiaotong University School Of Medicine, Shanghai, China

    Contact: Study coordinator (Xuefeng Wang)
  • Shenzhen Second People's Hospital, Shenzhen, China

    Contact: Study coordinator (Lisheng Cai)
  • The First Affiliated Hospital of Soochow University, Suzhou, China

    Contact: Study coordinator (Ziqiang Yu)
  • The Second Hospital of Shanxi Medical University, Taiyuan, China

    Contact: Study coordinator (Yanping Ma)
  • North China University of Science and Technology Affiliated Hospital, Tangshan, China

    Contact: Study coordinator (Zhenyu Yan)
  • Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

    Contact: Study coordinator (Renchi Yang, PhD) · rcyang65@163.com
  • Affiliated Hospital of Jiangnan University, Wuxi, China

    Contact: Study coordinator (Haiying Hua)
  • The First Affiliated Hospital of Xiamen University, Xiamen, China

    Contact: Study coordinator (Bing Xu)
  • Zhenyu Li, Xuzhou, China

    Contact: Study coordinator (Zhenyu Li)
  • Subei People's Hospital of Jiangsu province, Yangzhou, China

    Contact: Study coordinator (Mei Sun)
  • Henan Cancer Hospital, Zhengzhou, China

    Contact: Study coordinator (Hu Zhou)
  • Henan Provincial People's Hospital, Zhengzhou, China

    Contact: Study coordinator (Pingchong Lei)
  • Zhengzhou People's Hospital, Zhengzhou, China

    Contact: Study coordinator (Shuxia Guo)
מובילי המחקר
  • Renchi Yang

    Study Chair

    Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College.